Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Tanaka%2C+Yoshiya%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22Tanaka%2C+Yoshiya%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22Tanaka%2C+Yoshiya%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (14)
1
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors : 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
enthalten in:
RMD open
| 2024
von
Coates, L.
|
Landewé, R.
|
McInnes, I.
| +15
Wird geladen...
2
Safety profile of baricitinib in patients with systemic lupus erythematosus : an integrated analysis
enthalten in:
RMD open
| 2023
von
Morand, E.
|
Smolen, J.
|
Petri, M.
| +8
Wird geladen...
3
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions : an update
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Aletaha, D.
|
Kerschbaumer, A.
|
Kastrati, K.
| +41
Wird geladen...
4
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2023
von
Kalunian, K.
|
Furie, R.
|
Morand, E.
| +12
CommentIn: Nat Rev Rheumatol. 2023 Feb;19(2):64. - PMID 36596927
Wird geladen...
5
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
enthalten in:
Inflammation and regeneration
| 2023
von
Tanaka, Y.
Wird geladen...
6
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
enthalten in:
Inflammation and regeneration
| 2023
von
Tanaka, Y.
Wird geladen...
7
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
enthalten in:
Inflammation and regeneration
| 2023
von
Tanaka, Y.
Wird geladen...
8
Janus kinase-targeting therapies in rheumatology : a mechanisms-based approach
enthalten in:
Nature reviews. Rheumatology
| 2022
von
Tanaka, Y.
|
Luo, Y.
|
O'Shea, J.
| +1
Wird geladen...
9
Prevention of infective complications in systemic lupus erythematosus : A systematic literature review for the APLAR consensus statements
enthalten in:
International journal of rheumatic diseases
| 2021
von
Oku, K.
|
Hamijoyo, L.
|
Kasitanon, N.
| +5
Wird geladen...
10
Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic
enthalten in:
International journal of rheumatic diseases
| 2021
von
Tam, L.
|
Tanaka, Y.
|
Handa, R.
| +18
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
14
Aufsätze
14
E-Artikel
14
E-Ressourcen
Zeitschriftentitel
4
International journal of rheumatic diseases
3
Inflammation and regeneration
2
International Journal of Rheumatic Diseases
2
RMD open
1
Annals of the rheumatic diseases
1
Arthritis & rheumatology (Hoboken, N.J.)
1
Nature reviews. Rheumatology
Alle anzeigen ...
weniger ...
Thema
9
Journal Article
4
Review
4
SARS-CoV-2
4
baricitinib
3
Clinical Trial, Phase III
3
Covid-19
3
JAK
3
NAK family
3
Research Support, Non-U.S. Gov't
3
treatment
2
Antibodies, Monoclonal, Humanized
2
Antirheumatic Agents
2
Immunosuppressive Agents
2
Randomized Controlled Trial
2
biological therapy
1
09495UIM6V
1
38RL9AE51Q
1
APLAR guidance
1
Anti-Infective Agents
1
Asia Pacific
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
6
2023
1
2022
2
2021
4
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...